🇺🇸 FDA
Patent

US 9233932

Oligomer-nitroimidazole anti-infective conjugates

granted A61KA61K47/60A61P

Quick answer

US patent 9233932 (Oligomer-nitroimidazole anti-infective conjugates) held by Nektar Therapeutics expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K47/60, A61P, A61P31/00, A61P31/04